insights_auto
Why is 6869 up 2.40%?
Dive Deeperchevron_right
6869:TYO
Sysmex Corp
Â¥2,065.50
arrow_upward
+2.40%(+48.50) 1D
Nov 6, 3:30:00 PM GMT+9 · JPY
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 6869...
Open
Â¥2,002
High
Â¥2,106
Low
Â¥1,978
Mkt. cap
1.26T
Avg. vol.
3.12M
Volume
8.63M
Dividend
1.74%
Quarterly dividend
Â¥9
Ex-dividend date
Sep 29, 2026
P/E ratio
32.40
52-wk high
Â¥2,106
52-wk low
Â¥1,246
EPS
Â¥64
Shares outstanding
208.64M
No. of employees
11K
Open
Â¥2,002
High
Â¥2,106
Low
Â¥1,978
Mkt. cap
1.26T
Avg. vol.
3.12M
Volume
8.63M
Dividend
1.74%
Quarterly dividend
Â¥9
Ex-dividend date
Sep 29, 2026
P/E ratio
32.40
52-wk high
Â¥2,106
52-wk low
Â¥1,246
EPS
Â¥64
Shares outstanding
208.64M
No. of employees
11K
News stories
From web sources and news partners
Investing.com
·
52 minutes ago
S&P cuts Uganda outlook to stable on oil delays and widening fiscal deficit
Nacionale
·
41 minutes ago
Was Thursday's stock market drop the biggest ever? In points, yes. In percent, not even close
marketscreener.com
·
48 minutes ago
Tech-Heavy Nasdaq Rebounds at End of Bruising Week For Wall Street
www.tmgm.com
·
1 hour ago
United States CFTC S&P 500 NC Net Positions up to $-129.4K from previous $-134.4K
Profile
Sysmex Corporation is a Japanese company headquartered in Kobe that is engaged in the health care business. Originally called TOA Medical Electronics, the Sysmex brand was established in 1978, and were mainly involved with haematology analysers. The company was renamed Sysmex Corporation in 1998 taking advantage of brand recognition of their machines. Wikipedia
About Sysmex Corp
CEOHisashi Ietsugu
Employees10.9K
FoundedFeb 20, 1968
HeadquartersKobe, Hyogo, Japan
SectorHealth Care
IndustryMedical device
Websitesysmex.co.jp
Previous reports
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in JPY | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 126.80B | 133.74B | 138.84B | 130.67B |
Cost of goods sold | 58.70B | 67.18B | 70.79B | 64.36B |
Cost of revenue | 58.70B | 67.18B | 70.79B | 64.36B |
Research and development expenses | 6.80B | 7.98B | -20.44B | 7.21B |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 39.58B | 43.24B | 73.31B | 42.61B |
Operating expense | 45.76B | 51.35B | 53.20B | 51.49B |
Total operating expenses | 104.47B | 118.52B | 123.99B | 115.85B |
Operating income | 22.33B | 15.22B | 14.85B | 14.82B |
Other non operating income | -1.00M | 1.50M | -640.00M | -1.00M |
EBT including unusual items | 22.08B | 9.55B | 1.58B | 14.11B |
EBT excluding unusual items | 22.08B | 15.33B | 14.70B | 14.11B |
Income tax expense | 7.70B | 1.29B | -272.00M | 5.49B |
Effective tax rate | 34.85% | 13.53% | -17.22% | 38.94% |
Other operating expenses | -609.00M | 129.00M | 337.00M | 1.66B |
Net income | 14.47B | 8.22B | 1.76B | 8.69B |
Net profit margin | 11.41% | 6.15% | 1.27% | 6.65% |
Earnings per share | - | - | - | - |
Interest and investment income | 243.00M | 212.00M | 541.00M | 245.00M |
Interest expense | -905.00M | -1.27B | - | -1.27B |
Net interest expenses | -662.00M | -1.06B | 541.00M | -1.03B |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 34.40B | 27.02B | 26.47B | 26.85B |
Gain or loss from assets sale | 100.00M | 313.50M | 11.72B | 148.00M |
Upcoming events